Placebo to match alks 2680/alixorexton
Sponsors
Alkermes Inc.
Conditions
Narcolepsy Type 1
Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Not yet recruitingCTIS2025-523911-13-00
Target: 56Updated: 2026-06-03
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Not yet recruitingCTIS2025-524711-36-00
Target: 12Updated: 2026-07-21